Large-scale testing (Phase 3)Study completedNCT04447469
What this trial is testing
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation
Who this might be right for
COVID
Kiniksa Pharmaceuticals International, plc 814